X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs UNICHEM LAB - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT UNICHEM LAB WOCKHARDT/
UNICHEM LAB
 
P/E (TTM) x -18.0 221.8 - View Chart
P/BV x 1.3 0.6 211.7% View Chart
Dividend Yield % 0.0 2.3 0.1%  

Financials

 WOCKHARDT   UNICHEM LAB
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
UNICHEM LAB
Mar-19
WOCKHARDT/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,012292 346.6%   
Low Rs532182 292.0%   
Sales per share (Unadj.) Rs355.9167.7 212.2%  
Earnings per share (Unadj.) Rs-60.3-3.6 1,660.2%  
Cash flow per share (Unadj.) Rs-46.85.9 -787.0%  
Dividends per share (Unadj.) Rs0.014.00 0.3%  
Dividend yield (eoy) %01.7 0.1%  
Book value per share (Unadj.) Rs257.8372.3 69.3%  
Shares outstanding (eoy) m110.6370.38 157.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.21.4 153.4%   
Avg P/E ratio x-12.8-65.3 19.6%  
P/CF ratio (eoy) x-16.539.9 -41.4%  
Price / Book Value ratio x3.00.6 470.2%  
Dividend payout %0-110.2 0.0%   
Avg Mkt Cap Rs m85,37916,680 511.9%   
No. of employees `0006.32.6 240.4%   
Total wages/salary Rs m9,3712,393 391.6%   
Avg. sales/employee Rs Th6,295.04,535.2 138.8%   
Avg. wages/employee Rs Th1,498.3919.8 162.9%   
Avg. net profit/employee Rs Th-1,066.3-98.2 1,085.8%   
INCOME DATA
Net Sales Rs m39,36911,801 333.6%  
Other income Rs m1,202984 122.2%   
Total revenues Rs m40,57112,785 317.3%   
Gross profit Rs m18-835 -2.2%  
Depreciation Rs m1,495674 222.0%   
Interest Rs m2,55575 3,397.5%   
Profit before tax Rs m-2,830-600 471.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257-343 -74.8%   
Profit after tax Rs m-6,669-256 2,609.7%  
Gross profit margin %0-7.1 -0.7%  
Effective tax rate %-9.157.3 -15.9%   
Net profit margin %-16.9-2.2 782.2%  
BALANCE SHEET DATA
Current assets Rs m33,79620,384 165.8%   
Current liabilities Rs m26,9175,029 535.2%   
Net working cap to sales %17.5130.1 13.4%  
Current ratio x1.34.1 31.0%  
Inventory Days Days79105 75.7%  
Debtors Days Days89135 66.2%  
Net fixed assets Rs m39,6649,023 439.6%   
Share capital Rs m553141 392.9%   
"Free" reserves Rs m27,96826,058 107.3%   
Net worth Rs m28,52226,199 108.9%   
Long term debt Rs m21,7310-   
Total assets Rs m81,62031,496 259.1%  
Interest coverage x-0.1-7.0 1.5%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.50.4 128.7%   
Return on assets %-5.0-0.6 880.3%  
Return on equity %-23.4-1.0 2,397.2%  
Return on capital %-7.7-2.0 383.9%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,8078,188 119.8%   
Fx outflow Rs m1,789596 300.1%   
Net fx Rs m8,0197,592 105.6%   
CASH FLOW
From Operations Rs m684-3,278 -20.9%  
From Investments Rs m6,302-2,860 -220.4%  
From Financial Activity Rs m-7,695-24 31,796.3%  
Net Cashflow Rs m-664-4,690 14.2%  

Share Holding

Indian Promoters % 74.5 50.1 148.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 15.1 15.2%  
FIIs % 7.7 3.0 256.7%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 31.7 48.6%  
Shareholders   67,757 20,176 335.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 250 Points; Metal & Realty Stocks Drag(12:30 pm)

Share markets in India are presently trading on a negative note. All sectoral indices are trading in red with stocks in the metal sector, realty sector and capital goods sector.

Related Views on News

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Driverless Cars are Here. And This Tiny Company is in the Lead...(The 5 Minute Wrapup)

Jul 17, 2019

This future-ready company thrives on the pace of technological change.

Here's Why This Smallcap Will Beat the Big Autos in the EV Race(Profit Hunter)

Jul 16, 2019

As the conventional auto sector faces existential crisis, my latest smallcap recommendation is all set to ride the electric vehicle disruption and rise in new age vehicles.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 24, 2019 12:21 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS